Digital Therapeutics Market

Digital Therapeutics Market Size by Product Type (Software and Services), Application [Treatment Related Applications (Chronic Respiratory Diseases, Cardiovascular Diseases, Gastrointestinal Diseases, CNS Disorders, Musculoskeletal Diseases, Addiction Management and Others) and Preventive Applications (Obesity, Nutrition, Prediabetes and Others)], End-users (Payers, Employers, Patients, Providers and Others), Sales Channel (B2B and B2C), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-12677
  • Published Date: Mar, 2022
  • Pages: 234
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global digital therapeutics market was valued at USD 6.11 Billion in 2022 and grew at a CAGR of 23.09% from 2023 to 2032. The market is expected to reach USD 48.78 Billion by 2032. The growth of the digital therapeutics market can be attributed to the rise in demand for remote patient monitoring, regular assistance and continuous access to care. With the rising incidence of chronic ailments, the demand for digital therapeutics is also increasing simultaneously.

Market Introduction:

Software-driven evidence-based treatments for managing, preventing, or treating diseases or medical disorders are known as digital therapeutics. To put it another way, DTx is a clinically validated patient-facing software program that assists patients in managing, treating, or preventing a condition. Digital therapeutics, for instance, can assist patients in controlling their symptoms independently, improving various clinical endpoints and their quality of life. To encourage patients to change their behaviour, DTx employs digital technologies such as smartphones, sensors, the Internet of Things, and other gadgets. DTx can be utilized as a stand-alone treatment or combined with other, more traditional therapies such as medication, in-person therapy, specific hardware or other mechanical or sensory equipment. The gathering and analysis of digital measurements are necessary for the treatment.

Digital Therapeutics Market Size

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers

Increasing requirement for reducing healthcare costs: By cutting direct and indirect expenses, digital therapeutics can lower healthcare expenditures. Additionally, DTx can enhance client involvement, health outcomes, and access to care. DTx can lower obstacles to behavioural health treatment for populations that are difficult to reach and conditions that are difficult to treat. Digital therapeutics solves many financial difficulties in delivering healthcare and may be the solution that payers seek because of their lower direct and indirect costs. DTx assistance contributes to cost-effectiveness by directly reducing hospital stays and in-person physical therapy. Nevertheless, the overall net cost to payers is anticipated to drop, given the immediate savings that DTx can offer by eliminating human resources.

Restraints:

High installation cost of devices: The wide variety in temperatures inside and outside cars is the largest issue with automobile electronics. Lack of cooling can prevent chips from malfunctioning and age too quickly. Performance chips raise emissions, can harm the engine, and can result in misfires when they are exposed to higher temperatures.

Opportunities:

Increasing cases of chronic diseases: Due to the rising incidence of chronic diseases, including cardiovascular diseases, chronic respiratory diseases, diabetes, etc., the medical industry is expanding more quickly than ever. Reliable and effective testing procedures use several developing technologies. The digital therapeutics are intended to identify symptoms early so that therapy can start as soon as possible. The early detection of chronic diseases increases the likelihood of a successful treatment. The capacity of diagnostic procedures to recognize and detect chronic diseases is growing in prominence. The fast-track product approvals also provide growth prospects for the market to diagnose and treat such diseases. As a result, research and the creation of treatment strategies are encouraged by the growing cases of chronic diseases.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant digital therapeutics market, with a 38.23% market revenue share in 2022.

North America region will account for the largest market share with revenue growth. The growing number of investments in the digitalization of healthcare systems across the region leads to adoption digital therapeutics. Also, government initiatives are promoting digital therapeutics by offering incentives. The prominent global players have manufacturing bases in regional countries, propelling the market's growth.

North America region Digital Therapeutics Market Share in 2022 - 38.23%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Product Type Segment Analysis

The product type segment is divided into software and services. The software segment dominated the market, with a share of around 79.05% in 2022. Digital therapeutics software programs provide behaviour suggestions, health-related advice, medication intake notifications, workout regimens, and other features to assist patients in managing a range of ailments and diseases.

Application Segment Analysis

The application segment is divided into treatment-related applications and preventive applications. The treatment-related applications segment includes chronic respiratory diseases, cardiovascular diseases, gastrointestinal diseases, CNS disorders, musculoskeletal diseases, addiction management and others. The preventive applications segment further includes obesity, nutrition, prediabetes and others. The treatment-related applications segment dominated the market, with a share of around 68.19% in 2022. Adequate and evidence-based therapies for physical and chronic mental health issues can be managed with the help of digital therapeutics. Medical professionals can fill in treatment and delivery gaps using digital therapeutics solutions that may not be possible with more traditional approaches.

End-users Analysis

The end-users segment is divided into payers, employers, patients, providers and others. The patients segment dominated the market, with a share of around 36.02% in 2022. Patients are now widely adopting the use of digital therapeutics. With the help of digital therapeutics, patients can receive personalized and evidence-based treatment procedures. Patients can get real-time treatment, which improves the efficiency of the treatment.

Sales Channel Segment Analysis

The sales channel segment is divided into B2B and B2C. The B2B segment dominated the market, with a share of around 78.10% in 2022. A business-to-business company offers goods or services to other businesses. Healthcare institutions prefer to buy software devices from the B2B sales channel.

Some of the Key Market Players:
  • Welldoc, Inc.
  • OMADA HEALTH, INC.
  • Teladoc Health, Inc.
  • Limbix Health, Inc.
  • 2Morrow, Inc
  • Propeller Health
  • CANARY HEALTH
  • Fitbit LLC
  • Noom, Inc.
  • Akili Interactive Labs, Inc.
  • Pear Therapeutics, Inc.
  • HYGIEIA
  • BigHealth
  • DarioHealth Corp.
  • GAIA AG
  • Mango Health

Report Description: 

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 6.11 Billion
Market size value in 2032 USD 48.78 Billion
CAGR (2023 to 2032) 23.09%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product Type, Application, End-users and Sales Channel

Frequesntly Asked Questions

As per The Brainy Insights, the size of the digital therapeutics market was valued 6.11 billion in 2022 to USD 48.78 Billion by 2032.

Global digital therapeutics market is growing at a CAGR of 23.09% during the forecast period 2023-2032.

North America region emerged as the largest market for the digital therapeutics.

The market's growth will be influenced by the growing usage of digital therapeutics for reducing the healthcare cost.

The data privacy issues can hamper the market growth.

The increasing cases of chronic diseases are providing huge opportunities to the market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Product Type
          4.3.2. Market Attractiveness Analysis by Application
          4.3.3. Market Attractiveness Analysis by End-users
          4.3.4. Market Attractiveness Analysis by Sales Channel
          4.3.5. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing demand for digital therapeutics to reduce healthcare cost
    5.3. Restraints
          5.3.1. Instalment cost of devices
    5.4. Opportunities
          5.4.1. Increasing prevalence of chronic diseases
    5.5. Challenges
          5.5.1. Data privacy issues

6. Global Digital Therapeutics Market Analysis and Forecast, By Product Type
    6.1. Segment Overview
    6.2. Software
    6.3. Services

7. Global Digital Therapeutics Market Analysis and Forecast, By Application
    7.1. Segment Overview
    7.2. Treatment Related Applications
          7.2.1. Chronic Respiratory Diseases
          7.2.2. Cardiovascular Diseases
          7.2.3. Gastrointestinal Diseases
          7.2.4. CNS Disorders
          7.2.5. Musculoskeletal Diseases
          7.2.6. Addiction Management
          7.2.7. Others
    7.3. Preventive Applications
          7.3.1. Obesity
          7.3.2. Nutrition
          7.3.3. Prediabetes
          7.3.4. Others

8. Global Digital Therapeutics Market Analysis and Forecast, By End-users
    8.1. Segment Overview
    8.2. Payers
    8.3. Employers
    8.4. Patients
    8.5. Providers
    8.6. Others

9. Global Digital Therapeutics Market Analysis and Forecast, By Sales Channel
    9.1. Segment Overview
    9.2. B2B
    9.3. B2C

10. Global Digital Therapeutics Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Digital Therapeutics Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in the Digital Therapeutics Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Welldoc, Inc.
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. OMADA HEALTH, INC.
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. Teladoc Health, Inc.
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. Limbix Health, Inc.
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. 2Morrow, Inc.
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. Propeller Health
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. CANARY HEALTH
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. Fitbit LLC
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Noom, Inc.
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. Akili Interactive Labs, Inc.
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
    12.11. Pear Therapeutics, Inc.
          12.11.1. Business Overview
          12.11.2. Company Snapshot
          12.11.3. Company Market Share Analysis
          12.11.4. Company Product Portfolio
          12.11.5. Recent Developments
          12.11.6. SWOT Analysis
    12.12. HYGIEIA
          12.12.1. Business Overview
          12.12.2. Company Snapshot
          12.12.3. Company Market Share Analysis
          12.12.4. Company Product Portfolio
          12.12.5. Recent Developments
          12.12.6. SWOT Analysis
    12.13. BigHealth
          12.13.1. Business Overview
          12.13.2. Company Snapshot
          12.13.3. Company Market Share Analysis
          12.13.4. Company Product Portfolio
          12.13.5. Recent Developments
          12.13.6. SWOT Analysis
    12.14. DarioHealth Corp.
          12.14.1. Business Overview
          12.14.2. Company Snapshot
          12.14.3. Company Market Share Analysis
          12.14.4. Company Product Portfolio
          12.14.5. Recent Developments
          12.14.6. SWOT Analysis
    12.15. GAIA AG
          12.15.1. Business Overview
          12.15.2. Company Snapshot
          12.15.3. Company Market Share Analysis
          12.15.4. Company Product Portfolio
          12.15.5. Recent Developments
          12.15.6. SWOT Analysis
    12.16. Mango Health
          12.16.1. Business Overview
          12.16.2. Company Snapshot
          12.16.3. Company Market Share Analysis
          12.16.4. Company Product Portfolio
          12.16.5. Recent Developments
          12.16.6. SWOT Analysis
 

List of Table

1. Global Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

2. Global Software, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

3. Global Services, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

4. Global Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

5. Global Treatment Related Applications, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

6. Global Preventive Applications, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion)

7. Global Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

8. Global Payers, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

9. Global Employers, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

10. Global Patients, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

11. Global Providers, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

12. Global Others, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

13. Global Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

14. Global B2B Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

15. Global B2C, Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

16. Global Digital Therapeutics Market, By Region, 2019-2032 (USD Billion) 

17. North America Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

18. North America Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

19. North America Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion)

20. North America Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

21. U.S. Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

22. U.S. Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

23. U.S. Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

24. U.S. Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

25. Canada Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

26. Canada Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

27. Canada Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

28. Canada Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

29. Mexico Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

30. Mexico Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

31. Mexico Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

32. Mexico Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

33. Europe Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

34. Europe Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

35. Europe Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion)

36. Europe Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

37. Germany Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

38. Germany Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

39. Germany Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

40. Germany Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

41. France Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

42. France Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

43. France Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

44. France Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

45. U.K. Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

46. U.K. Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

47. U.K. Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

48. U.K. Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

49. Italy Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

50. Italy Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

51. Italy Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

52. Italy Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

53. Spain Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

54. Spain Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

55. Spain Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

56. Spain Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

57. Asia Pacific Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

58. Asia Pacific Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

59. Asia Pacific Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

60. Asia Pacific Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

61. Japan Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

62. Japan Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

63. Japan Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion)

64. Japan Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

65. China Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

66. China Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

67. China Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

68. China Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

69. India Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

70. India Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

71. India Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

72. India Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

73. South America Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

74. South America Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

75. South America Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

76. South America Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

77. Brazil Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

78. Brazil Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

79. Brazil Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

80. BrazilDigital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

81. Middle East and Africa Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

82. Middle East and Africa Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

83. Middle East and Africa Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

84. Middle East and Africa Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

85. UAE Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

86. UAE Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

87. UAE Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

88. UAE Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion) 

89. South Africa Digital Therapeutics Market, By Product Type, 2019-2032 (USD Billion) 

90. South Africa Digital Therapeutics Market, By Application, 2019-2032 (USD Billion) 

91. South Africa Digital Therapeutics Market, By End-users, 2019-2032 (USD Billion) 

92. South Africa Digital Therapeutics Market, By Sales Channel, 2019-2032 (USD Billion)  

List of Figures

1. Global Digital Therapeutics Market Segmentation

2. Digital Therapeutics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Digital Therapeutics Market Attractiveness Analysis by Product Type

9. Global Digital Therapeutics Market Attractiveness Analysis by Application

10. Global Digital Therapeutics Market Attractiveness Analysis by End-users

11. Global Digital Therapeutics Market Attractiveness Analysis by Sales Channel

12. Global Digital Therapeutics Market Attractiveness Analysis by Region

13. Global Digital Therapeutics Market: Dynamics

14. Global Digital Therapeutics Market Share by Product Type (2022 & 2032)

15. Global Digital Therapeutics Market Share by Application (2022 & 2032)

16. Global Digital Therapeutics Market Share by End-users (2022 & 2032)

17. Global Digital Therapeutics Market Share by Sales Channel (2022 & 2032)

18. Global Digital Therapeutics Market Share by Regions (2022 & 2032)

19. Global Digital Therapeutics Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global digital therapeutics market based on below mentioned segments:

Global Digital Therapeutics Market by Product Type:

  • Software
  • Services

Global Digital Therapeutics Market by Application:

  • Treatment Related Applications
    • Chronic Respiratory Diseases
    • Cardiovascular Diseases
    • Gastrointestinal Diseases
    • CNS Disorders
    • Musculoskeletal Diseases
    • Addiction Management
    • Others
  • Preventive Applications
    • Obesity
    • Nutrition
    • Prediabetes
    • Others

Global Digital Therapeutics Market by End-users:

  • Payers
  • Employers
  • Patients
  • Providers
  • Others

Global Digital Therapeutics Market by Sales Channel:

  • B2B
  • B2C

Global Digital Therapeutics Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date